Cicloprolol
Chemical compound
![]() |
|
Names | |
---|---|
IUPAC name
1-[4-[2-(Cyclopropylmethoxy)ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol
|
|
Identifiers | |
3D model (
JSmol
)
|
|
ChEMBL | |
ChemSpider | |
KEGG | |
PubChem
CID
|
|
UNII | |
|
|
|
|
Properties | |
C 18 H 29 N O 4 | |
Molar mass | 323.433 g·mol −1 |
Except where otherwise noted, data are given for materials in their
standard state
(at 25
°C [77
°F], 100
kPa).
|
Cicloprolol is a beta-adrenoceptor antagonist . [1]
Synthesis
![](http://upload.wikimedia.org/wikipedia/commons/thumb/0/03/Cicloprolol_synthesis.svg/500px-Cicloprolol_synthesis.svg.png)
See also
References
- ↑ Cocco, G; Alfiero, R; Pouleur, H (1992). "An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure" . Clinical Cardiology . 15 (1): 38–42. doi : 10.1002/clc.4960150109 . PMID 1347258 .
- ↑ DE 2649605 , Manoury, Philippe Michel Jacques; Cavero, Icilio Angelo Girolamo & Majer, Henry et al., "Phenoläther, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimttel [Phenol ethers, processes for their preparation and medicinal products containing them]", published 1977-05-18, assigned to Synthelabo S.A.
- ↑ P. M. J. Manouri, I. A. G. Carero, H. Majer, and P. R. L. Giudicelli, (1977) Chem. Abstr., 87:134,543j (1977). eidem U.S. Patent 4,311,708
![]() |
This drug article relating to the cardiovascular system is a stub . You can help Wikipedia by expanding it . |